Building on previous research that identified metastatic-niche-specific metabolic vulnerabilities, researchers investigated how a ketogenic diet enhances estrogen receptor-positive liver metastatic breast cancer’s response to Fulvestrant treatment.
[NPJ Breast Cancer]